Abstract:Circulation, Volume 146, Issue Suppl_1, Page A11622-A11622, November 8, 2022. Doxorubicin, an anthracycline drug, is a key drug in the treatment for diffuse large B-cell lymphoma (DLBCL). It is contraindicated in patients with serious heart diseases due to the cardiotoxicity. Transcatheter aortic valve replacement (TAVR) has been an established treatment for patients with severe aortic stenosis (AS) at high or prohibitive risk for surgical aortic valve replacement (SAVR). A 67-year-old woman was referred to our department with severe AS. Two months ago, the patient presented with bilateral cervical and inguinal lymphadenopathy. A biopsy of the lymph nodes revealed the primary diffuse large B-cell lymphoma (DLBCL). The patient had been diagnosed with stage IVA non-Hodgkin lymphoma according to the Ann Arbor staging system. The echocardiogram demonstrated a left ventricular ejection fraction of 67% and severe bicuspid AS with a peak velocity of 4.1 m/sec, mean pressure gradient of 44.1 mmHg, and aortic valve area of 0.58 cm2. She was initially treated with chemotherapy without anthracycline due to the high risk of anthracycline cardiotoxicity. However, anthracyclines were thought to be essential for controlling DLBCL. She was referred to our department and evaluated from the heart-team, which considered the following characteristics: severe impairment of mobility and frailty with a Society of Thoracic Surgeons (STS) score of 5.99%. Due to the high surgical risk for SAVR, we decided to perform TAVR. The procedure was completed without complications during the perioperative period. Ten days after TAVR, the patient received the therapy of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone), which resulted in complete remission without cardiac symptoms. Before the advent of TAVR, it was difficult for patients with both severe AS and cancer to receive surgery and/or cardiotoxic treatment. In patients with cancer, AS may interfere with optimal antineoplastic therapy (ie, high-risk oncological surgery and/or cardiotoxic anticancer drugs). TAVR does not need cardiac arrest, extracorporeal circulation, and thoracotomy. TAVR could increase therapeutic options in cancer patients with severe AS who are at high surgical risk.

Successful Treatment of Malignant Lymphoma Following Transcatheter Aortic Valve Replacement: A Case Report

Abstract 11622: A Case of Successful Malignant Lymphoma Treatment Following Transcatheter Aortic Valve Replacement

Thrombotic Thrombocytopenia Purpura (TTP) Following Emergent Aortic Valve Replacement after a Complicated TAVR Procedure: a Case Report and Review of the Literature

Successful Treatment of Systemic Sclerosis Complicated by Ventricular Tachycardia with a Cardiac Resynchronization Therapy-Defibrillator: A Case Report

Transcatheter aortic valve replacement before to breast cancer management: case report and literature review

Rest, replace, and recover: TandemHeart to transcatheter aortic valve replacement-a case report

Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy in a Patient with Prior Transcatheter Aortic Valve Replacement

Beating aortic valve replacement surgery as an alternative to transcatheter aortic valve implantation in a patient with severe aortic stenosis and left ventricular dysfunction

Outcomes of Patients with Severe Symptomatic Aortic Valve Stenosis after Chest Radiation: Transcatheter Versus Surgical Aortic Valve Replacement

[Successful percutaneous treatment of complex heart disease in a stage IV non-small cell lung cancer survivor]

Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Malignancy

A case report: transfemoral transcatheter aortic valve replacement with a dedicated valve system for severe aortic regurgitation in a patient with a left ventricular assist device

[Rupture of hepatic lesion of diffuse large B-cell lymphoma following immunochemotherapy]

Case Report: Minimally Invasive Therapy by Transcatheter Aortic Valve Replacement and Percutaneous Intramyocardial Septal Radiofrequency Ablation for a Patient With Aortic Stenosis Combined With Hypertrophic Obstructive Cardiomyopathy: Two-Year Follow-Up Results

Redo-TAVR for bioprosthetic valve degeneration with obvious neoplasm in a left cerebral infarction patient

Short-term results with transcatheter aortic valve replacement for treatment of left ventricular assist device patients with symptomatic aortic insufficiency

Successful Operation Following Neoadjuvant Immunotherapy Combined with Chemotherapy for Right Aortic Arch with Esophageal Cancer: A Case Report

Cardiovascular Disorder after Cardiotoxic Non-Hodking’s Lymphoma Treatment: A Case Report

Transcatheter aortic valve intervention in patients with cancer

Successful management of postoperative tracheal metastasis in small cell lung cancer with radiotherapy and durvalumab: A case report

Successful Treatment with Hepatic Arterial Infusion Chemotherapy in a Breast Cancer Patient with Multiple Liver Metastases Who Declined Systemic Therapy